Evidence map›Paper›PMID 29721316›Full record

ArticleJournal of nutritional science2018

Effects of dietary supplementation with milk fat globule membrane on the physical performance of community-dwelling Japanese adults: a randomised, double-blind, placebo-controlled trial.

Yasuo Kokai, Nana Mikami, Mitsuhiro Tada, Kazuichi Tomonobu, Ryuji Ochiai, Noriko Osaki, Yoshihisa Katsuragi, Hitoshi Sohma, Yoichi M Ito

Open access · goldAbstract read
In one paragraph

Article in Journal of nutritional science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Yasuo KokaiDepartment of Biomedical Engineering, Sapporo Medical University School of Medicine, S1W17, Chuo-ku, Sapporo, Japan.
Nana MikamiDepartment of Biomedical Engineering, Sapporo Medical University School of Medicine, S1W17, Chuo-ku, Sapporo, Japan.
Mitsuhiro TadaDepartment of Neurosurgery, Rumoi Municipal Hospital, 2-16-1 Shinonome, Rumoi, Japan.
Kazuichi TomonobuHealth Care Food Research Laboratory, Kao Corporation, Tachibana-2-1-3, Sumida-ku, Tokyo, Japan.
Ryuji OchiaiHealth Care Food Research Laboratory, Kao Corporation, Tachibana-2-1-3, Sumida-ku, Tokyo, Japan.
Noriko OsakiHealth Care Food Research Laboratory, Kao Corporation, Tachibana-2-1-3, Sumida-ku, Tokyo, Japan.
Yoshihisa KatsuragiHealth Care Food Research Laboratory, Kao Corporation, Tachibana-2-1-3, Sumida-ku, Tokyo, Japan.
Hitoshi SohmaDepartment of Educational Development, Sapporo Medical University Center for Medical Education, S1W17, Chuo-ku, Sapporo, Japan.
Yoichi M ItoDepartment of Biostatics, Hokkaido University Graduate School of Medicine, N15W7, Kita-ku, Sapporo, Japan.
Kao Corporation (Japan) · JPSapporo Medical University · JPHokkaido University · JPIzumi City General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted a randomised, double-blind, placebo-controlled trial to elucidate the effects of dietary milk fat globule membrane (MFGM) on the physical performance of community-dwelling Japanese adults. For this 24-week study, 115 middle-aged subjects (range 50-70 years old) were invited, of whom 113 (seventy-two women, forty-one men) completed the trial. Participants were then divided into either the placebo control or MFGM group. Measurements of physical performance (without undertaking any mandatory exercise) examining muscle strength, agility and balance were tested every 6 weeks until 24 weeks. Analyses were performed using the intention-to-treat method for all participants. Although the effects of MFGM on muscle strength and agility were not significant, we noted that the parameter for balance (such as the ability to stand on one leg with eyes closed for longer durations) increased in the MFGM group (mean 10·1 (95 % CI 8·25, 12·4) s) compared with the placebo (mean 7·53 (95 % CI 6·11, 9·30) s) (

Indexed as

AgeingAgilityBalancekwd>ALAT, alanine aminotransferasekwd>ASAT, aspartate aminotransferasekwd>MFGM, milk fat globule membranekwd>VM, vastus medialis of quadriceps femoris muscleMilk fat globule membraneOne-leg standPhysical performance

Identifiers

PMID29721316
PMCPMC5921044
OpenAlexW2803041349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.